← Open Payments lookup

JOAN ANDERSON: Open Payments

NPI 1902478811 · CLINTON, IA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,377 in 91 payments from 15 companies in 2025. Trend: 2023 $1,115 · 2024 $1,161 · 2025 $1,377

Food & beverage: $1,377
CompanyPaymentsAmount
Neurocrine BioSciences, Inc.28$236
Otsuka America Pharmaceutical, Inc.11$192
ABBVIE INC.10$183
Teva Pharmaceuticals USA, Inc.9$178
Supernus Pharmaceuticals, Inc.8$113
Alkermes, Inc.4$72
E.R. Squibb & Sons, L.L.C.4$69
Vanda Pharmaceuticals Inc.2$60
ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.)3$58
Axsome Therapeutics, Inc.3$55

Products named: INGREZZA, VRAYLAR, REXULTI, Qelbree, AUSTEDO XR, ABILIFY ASIMTUFII, ARISTADA, COBENFY.

Industry payments across IA — which companies pay providers there.